Phase 1: the 0.25mg starting dose (5 units) Do not expect weight loss during this phase
Many people find blander, lower-fat options easier to manage: eggs, plain chicken, yogurt, and protein smoothies
Retatrutide is a triple agonist that activates three receptors: GLP-1, GIP, and Glucagon
Cost: roughly $4
Although AOMs are generally not covered by Medicare, CMS has recently allowed Wegovy for patients that have both cardiovascular disease and obesitysuggesting potential future growth in this space
The article says patients with stable metabolic markers, no diabetes history, and a BMI below 27 typically do not qualify, unless significant cardiovascular risk or family history is documented